Beloborodov E, Iurova E, Fomin A, Saenko Y
Sovrem Tekhnologii Med. 2024; 16(2):5-14.
PMID: 39539754
PMC: 11556054.
DOI: 10.17691/stm2024.16.2.01.
Zheng L, Xu Z, Zhang W, Lin H, Zhang Y, Zhou S
Discov Oncol. 2024; 15(1):192.
PMID: 38806963
PMC: 11133253.
DOI: 10.1007/s12672-024-01058-1.
Qi-Lytle X, Sayers S, Wagner E
Int J Mol Sci. 2024; 25(1).
PMID: 38203281
PMC: 10778701.
DOI: 10.3390/ijms25010110.
Serafin P, Kleczkowska P
Pharmaceutics. 2023; 15(11).
PMID: 38004575
PMC: 10674911.
DOI: 10.3390/pharmaceutics15112597.
Koch T, Torres J, Baskin R, Florez Salcedo P, Chase K, Olivera B
Front Mol Neurosci. 2023; 16:1176662.
PMID: 37720554
PMC: 10501145.
DOI: 10.3389/fnmol.2023.1176662.
Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm.
Rosiek V, Kogut A, Kos-Kudla B
Cancers (Basel). 2023; 15(13).
PMID: 37444393
PMC: 10340053.
DOI: 10.3390/cancers15133282.
Novel neuroendocrine role of γ-aminobutyric acid and gastrin-releasing peptide in the host response to influenza infection.
Shirey K, Lai W, Sunday M, Cuttitta F, Blanco J, Vogel S
Mucosal Immunol. 2023; 16(3):302-311.
PMID: 36965691
PMC: 10330014.
DOI: 10.1016/j.mucimm.2023.03.004.
Proteogenomic links to human metabolic diseases.
Koprulu M, Carrasco-Zanini J, Wheeler E, Lockhart S, Kerrison N, Wareham N
Nat Metab. 2023; 5(3):516-528.
PMID: 36823471
PMC: 7614946.
DOI: 10.1038/s42255-023-00753-7.
Changes of Gastric Secretion after Bolus and Slow Intravenous Administration of Bombesin and Neurotensin.
Tsalis K, Ioannidis O, Mariorakis C, Christidis P, Loutzidou L, Mantzoros I
Maedica (Bucur). 2022; 16(4):642-655.
PMID: 35261667
PMC: 8897808.
DOI: 10.26574/maedica.2021.16.4.642.
Gastrin-releasing peptide regulates fear learning under stressed conditions via activation of the amygdalostriatal transition area.
Goto F, Kiyama Y, Ogawa I, Okuno H, Ichise T, Ichise H
Mol Psychiatry. 2022; 27(3):1694-1703.
PMID: 34997193
DOI: 10.1038/s41380-021-01408-3.
Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.
Moody T, Lee L, Ramos-Alvarez I, Iordanskaia T, Mantey S, Jensen R
Front Endocrinol (Lausanne). 2021; 12:728088.
PMID: 34539578
PMC: 8441013.
DOI: 10.3389/fendo.2021.728088.
The gastrin-releasing peptide/bombesin system revisited by a reverse-evolutionary study considering Xenopus.
Hirooka A, Hamada M, Fujiyama D, Takanami K, Kobayashi Y, Oti T
Sci Rep. 2021; 11(1):13315.
PMID: 34172791
PMC: 8233351.
DOI: 10.1038/s41598-021-92528-x.
Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N, Aghanejad A, Ahmadzadehfar H, Farzanehfar S, Eppard E
Int J Mol Sci. 2021; 22(9).
PMID: 33925632
PMC: 8125561.
DOI: 10.3390/ijms22094597.
The retrotrapezoid nucleus and the neuromodulation of breathing.
Moreira T, Sobrinho C, Falquetto B, Oliveira L, Lima J, Mulkey D
J Neurophysiol. 2021; 125(3):699-719.
PMID: 33427575
PMC: 7988753.
DOI: 10.1152/jn.00497.2020.
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies.
Hoppenz P, Els-Heindl S, Beck-Sickinger A
Front Chem. 2020; 8:571.
PMID: 32733853
PMC: 7359416.
DOI: 10.3389/fchem.2020.00571.
GRP receptor and AMPA receptor cooperatively regulate itch-responsive neurons in the spinal dorsal horn.
Kiguchi N, Uta D, Ding H, Uchida H, Saika F, Matsuzaki S
Neuropharmacology. 2020; 170:108025.
PMID: 32142790
PMC: 7754563.
DOI: 10.1016/j.neuropharm.2020.108025.
Design, synthesis and evaluation of PD176252 analogues for ameliorating cisplatin-induced nephrotoxicity.
Yao S, Wei B, Yu M, Meng X, He M, Yao R
Medchemcomm. 2019; 10(5):757-763.
PMID: 31191866
PMC: 6533884.
DOI: 10.1039/c8md00632f.
Neuromedin B receptor disruption impairs adipogenesis in mice and 3T3-L1 cells.
Silva Monteiro de Paula G, Wilieman M, Silva K, Baptista L, Boudina S, Souza L
J Mol Endocrinol. 2019; 63(1):93-102.
PMID: 31067509
PMC: 9931200.
DOI: 10.1530/JME-19-0032.
A Skin Secretion-Derived Novel Bombesin-Related Pentadecapeptide (Ranatensin-HLa) Evoke Myotropic Effects on the in vitro Rat Smooth Muscles.
Lin Y, Hu N, He H, Ma C, Zhou M, Wang L
Toxins (Basel). 2019; 11(4).
PMID: 30959738
PMC: 6521075.
DOI: 10.3390/toxins11040204.
First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist Ga-NODAGA-MJ9.
Gnesin S, Cicone F, Mitsakis P, Van Der Gucht A, Baechler S, Miralbell R
EJNMMI Res. 2018; 8(1):108.
PMID: 30543050
PMC: 6291411.
DOI: 10.1186/s13550-018-0462-9.
